Particle-emitting endoradiotherapeutic agent undergoing DNA incorporation

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1204-1209

  Vaidyanathan, Ganesan ^a   Larsen, Roy H ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ASTATO 2' DEOXYURIDINE; 5-ASTATO-2'-DEOXYURIDINE; DNA; DRUG DERIVATIVE; IDOXURIDINE; 5 ASTATODEOXYURIDINE AT 211; ASTATINE 211; DEOXYURIDINE DERIVATIVE; IODINE 131; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TUMOR; CELL CULTURE; GLIOMA; HALF LIFE TIME; HUMAN; LINEAR ENERGY TRANSFER; METABOLISM; SYNTHESIS; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; DRUG DNA BINDING; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN CELL; PRIORITY JOURNAL;

BRAIN NEOPLASMS; DNA, NEOPLASM; GLIOMA; HALF-LIFE; HUMANS; IDOXURIDINE; LINEAR ENERGY TRANSFER; TUMOR CELLS, CULTURED;

EID: 0029664662     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bloomer, W. D., and Adelstein, S. J. Iodine-125 cytotoxicity: implications for therapy and estimation of radiation risk Int. J. Nucl Med. Biol., 8: 171-178, 1981
2. 125I in mammalian cells. Radiat. Res., 111: 305-318, 1987
3. 125I]iodo-2′-deoxyuridine. Radiat. Res., 118, 532-544, 1989.
4. 125IUdR and other radiolabelled thymidiae precursors in resistant tumors Br. J Radiol., 64: 45-49, 1991.
5. Zalutsky, M. R., McLendon, R., Garg, P. K., Archer, G. E., Schuster, J. M , and Bigner, D. D. Radioimmunotherapy of neoplastic meningitis in rats using an α-particle-emitting immunoconjugate. Cancer Res., 54: 4719-4725, 1994.
6. 211At]astatobesuylguanidine on human neuroblastoma cells. Cancer Res., 54. 5414-5419, 1994.
7. 211At decay Radiochimica Acta, 47: 87-89, 1989
8. Baranowska-Kortylewicz, J., Helseth, L. D., Lai, J., Schneiderman, M. H., Schneiderman, G. S., and Dalrymple, G V. Radiolabeling kit/generators for 5-radiohalogenated uridines. J Labelled Compd. Radiopharm., 34: 513-521, 1994.
9. 211At reaction. Appl. Radiat. Isot., in press, 1996.
10. 123/125I]iodo-2′-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res., 50. 5199-5203, 1990.
11. Bigner, S. H., Friedman, H. S., Biegel, J. A , Wikstrand, C J., Mark, J , Gebhardt, R., Eng, L. F., and Bigner, D. D Specific chromosomal abnormalities characterize four established cell lines derived from malignant human gliomas. Acta Neuropathol., 72: 86-97, 1986.
12. Azure, M T., Archer, R. D., Sastry, K. S. R., Rao, D. V., and Howell, R. W. Biological effect of lead-212 localized in the nucleus of mammalian cells, role of recoil energy in the radiotoxicity of internal α-particle emitters. Radiation Res., 140: 276-283, 1994.
13. Hall, E J. Radiobiology for the Radiologist, pp. 161-177. Philadelphia Lippincott, 1988.
14. 2 fragments with the α particle emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity. Proc. Natl Acad. Sci. USA, 86: 7149-7153, 1989
15. Bloomer, W. D., McLaughlin, W. H., Neirinckx, R. D., Adelstein, S. J., Gordon, P. R., Ruth, T. J., and Wolf, A. P. Astatine-211 tellurium radiocolloid cures experimental malignant ascites. Science (Washington DC), 212: 340-341, 1981
16. 211At). J. Labelled Compd. Radiopharm., 13: 271, 1977
17. Visser, G. W. M., Diemer, E L., and Kaspersen, F. M. The preparation of aromatic astatine compounds through aromatic mercury compounds part II: astatination of pyrimidine and steroids. J. Labelled Compd. Radiopharm., 18: 799-807, 1981.
18. Berei, K., Eberle, S. H , Kirby, H. W , Münzel, H., Rössler, K., Seidel, A., and Vasäros, L Gmelin Handbook of Inorganic Chemistry - Astatine, pp. 107-128. Berlin. Springer-Verlag, 1985.
19. Mariani, G., Cei A., Collecchi, P , Baranowska-Kortylewicz, J , Van den Abbeele, A D., Di Luca, L., Di Stefano, R., Viacava, P., Ferdeghini, E M. Di Sacco, S., Salvadori, P. A., Bevilacqua, G., Adelstein, S J., Mosca, F., and Kassis, A. I. Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2′-deoxyuridine following intratumoral injection in patients with colorectal cancer. J. Nucl. Med., 34: 1175-1183, 1993
20. 2 fragment. Cancer Res., 50: 3514-3520, 1990.